Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00811759 · UNKNOWN

Trial details

NCT number: NCT00811759
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2007-06-01
Primary completion: 2009-05-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.